It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Polycystin 2 (PC2 or TRPP1, formerly TRPP2) is a calcium-permeant Transient Receptor Potential (TRP) cation channel expressed primarily on the endoplasmic reticulum (ER) membrane and primary cilia of all cell and tissue types. Despite its ubiquitous expression throughout the body, studies of PC2 have focused primarily on its role in the kidney, as mutations in PC2 lead to the development of autosomal dominant polycystic kidney disease (ADPKD), a debilitating condition for which there is no cure. However, the endogenous role that PC2 plays in the regulation of general cellular homeostasis remains unclear. In this study, we measure how PC2 expression changes in different pathological states, determine that its abundance is increased under conditions of cellular stress in multiple tissues including human disease, and conclude that PC2-deficient cells have increased susceptibility to cell death induced by stress. Our results offer new insight into the normal function of PC2 as a ubiquitous stress-sensitive protein whose expression is up-regulated in response to cell stress to protect against pathological cell death in multiple diseases.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details




1 Yale University, Department of Cellular and Molecular Physiology, New Haven, United States of America (GRID:grid.47100.32) (ISNI:0000000419368710)
2 Yale University, Department of Pharmacology, New Haven, United States of America (GRID:grid.47100.32) (ISNI:0000000419368710); Heidelberg University, Institute of Pharmacology, Heidelberg, Germany (GRID:grid.7700.0) (ISNI:0000 0001 2190 4373)
3 University of Illinois at Urbana-Champaign, Department of Molecular and Integrative Physiology, Urbana, United States of America (GRID:grid.35403.31) (ISNI:0000 0004 1936 9991); University of Illinois at Urbana-Champaign, Neuroscience Program, Urbana, United States of America (GRID:grid.35403.31) (ISNI:0000 0004 1936 9991)
4 Yale University, Department of Internal Medicine, New Haven, United States of America (GRID:grid.47100.32) (ISNI:0000000419368710)
5 Yale University, Department of Biomedical Engineering, New Haven, United States of America (GRID:grid.47100.32) (ISNI:0000000419368710)
6 Yale University, Department of Pathology, New Haven, United States of America (GRID:grid.47100.32) (ISNI:0000000419368710); Washington University in St. Louis, Department of Pathology and Immunology, St. Louis, United States of America (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002)
7 Washington University School of Medicine, Department of Medicine, Cardiovascular Division, St. Louis, United States of America (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002)
8 Yale University, Department of Pathology, New Haven, United States of America (GRID:grid.47100.32) (ISNI:0000000419368710)
9 Washington University School of Medicine, Department of Medicine, Cardiovascular Division, St. Louis, United States of America (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002); Washington University School of Medicine, Department of Developmental Biology, St. Louis, United States of America (GRID:grid.4367.6) (ISNI:0000 0001 2355 7002)
10 Yale University, Department of Cellular and Molecular Physiology, New Haven, United States of America (GRID:grid.47100.32) (ISNI:0000000419368710); Yale University, Department of Pharmacology, New Haven, United States of America (GRID:grid.47100.32) (ISNI:0000000419368710)